ERBB2 and breast cancer: Although BC is among the most investigated tumors, few comparable data are available regarding the association between tumor vasculature and microenvironment phenotype at the early stages, as well as clinical outcomes in order to integrate the prognostic and predictive value derived from the assessment of hormone receptors (ER and PR) and of HER2 status.